Clinical Trial Update: Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis [Phase 4]

View source ↗

Summary

Long-term Phase 4 study investigating Avonex therapy after a first attack in multiple sclerosis patients; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brainstem Cerebellar Syndrome
• Multiple Sclerosis
• Optic Neuritis
• Transverse Myelitis

Drugs mentioned

• Avonex (Interferon beta-1a)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Multiple Sclerosis, Optic Neuritis | Phase 4 | Status: COMPLETED | Results posted: 2017-09-06